Combined treatment for pain from bone metastases in patients with prostate cancer / 中华男科学杂志
National Journal of Andrology
; (12): 188-190, 2004.
Article
in Zh
| WPRIM
| ID: wpr-357052
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the effects of combined treatment of hormone therapy with strontium-89 for pain from bone metastases in patients with prostate cancer.</p><p><b>METHODS</b>Sixteen patients with metastasis prostate cancer received hormone therapy with strontium-89 chloride (89Sr), and 4 of them received radiotherapy.</p><p><b>RESULTS</b>The pain was relieved. Relief occurred in 75.6% of the patients for 3 months, 80.5% for 6 months and 63.4% for 9 months.</p><p><b>CONCLUSION</b>Hormone therapy enhances the effect of 89Sr without obvious toxicity. The combined treatment not only significantly raises pain palliation, prolongs pain-free survival, but improves the patients life quality.</p>
Full text:
1
Index:
WPRIM
Main subject:
Pain, Intractable
/
Prostatic Neoplasms
/
Strontium
/
Therapeutics
/
Bone Neoplasms
/
Combined Modality Therapy
/
Therapeutic Uses
/
Androgen Antagonists
Limits:
Aged
/
Aged80
/
Humans
/
Male
Language:
Zh
Journal:
National Journal of Andrology
Year:
2004
Type:
Article